Mycosis fungoides screening: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(4 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{CMycosis fungoides}}
{{Mycosis fungoides}}
{{CMG}}; {{AE}} {{S.G.}}
{{CMG}}; {{AE}} {{S.G.}}
==Overview==
==Overview==
* According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for cutaneous T cell lymphoma.
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for cutaneous T cell lymphoma.


==Screening==
==Screening==
* According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for [[cutaneous T cell lymphoma]].
* According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for mycosis fungoiseades.
* Visual skin examination to screen for skin cancer in adults should be helpful.<ref name="WernliHenrikson2016">{{cite journal|last1=Wernli|first1=Karen J.|last2=Henrikson|first2=Nora B.|last3=Morrison|first3=Caitlin C.|last4=Nguyen|first4=Matthew|last5=Pocobelli|first5=Gaia|last6=Blasi|first6=Paula R.|title=Screening for Skin Cancer in Adults|journal=JAMA|volume=316|issue=4|year=2016|pages=436|issn=0098-7484|doi=10.1001/jama.2016.5415}}</ref>


==References==
==References==
{{Reflist|1}}
{{Reflist|2}}


[[Category:Disease]]
[[Category:Up-To-Date]]
[[Category:Types of cancer]]
[[Category:Hematology]]
 
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Medicine]]
[[Category:Hematology]]
[[Category:Hematology]]
[[Category:Immunology]]

Latest revision as of 22:50, 29 July 2020

Mycosis fungoides Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mycosis Fungoides from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X-Ray

CT Scan

MRI

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mycosis fungoides screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mycosis fungoides screening

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mycosis fungoides screening

CDC on Mycosis fungoides screening

Mycosis fungoides screening in the news

Blogs on Mycosis fungoides screening

Directions to Hospitals Treating Mycosis fungoides

Risk calculators and risk factors for Mycosis fungoides screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]

Overview

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for cutaneous T cell lymphoma.

Screening

  • According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for mycosis fungoiseades.
  • Visual skin examination to screen for skin cancer in adults should be helpful.[1]

References

  1. Wernli, Karen J.; Henrikson, Nora B.; Morrison, Caitlin C.; Nguyen, Matthew; Pocobelli, Gaia; Blasi, Paula R. (2016). "Screening for Skin Cancer in Adults". JAMA. 316 (4): 436. doi:10.1001/jama.2016.5415. ISSN 0098-7484.